Martin I. Freed
CIK: 0001676653
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLDB
Solid Biosciences Inc.
Director
Discretionary Trading P&L
Holdings
About Freed Martin I
Freed Martin I (SEC CIK 0001676653) files insider reports with the SEC as Director of Solid Biosciences Inc. (SLDB).
Signal8 holds 2 ownership filings by Freed Martin I, all Form 4s, filed between Jun 13, 2025 and Jun 11, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Freed Martin I's filings is in CHARLESTOWN, MA.
Recent filings by Freed Martin I
Other insiders filing for Solid Biosciences Inc. (SLDB)
- Ganot Ilan, Director
- Brooks Gabriel, Chief Medical Officer
- SMITH IAN F, Director
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- Nagendran Sukumar, Director
- PERCEPTIVE ADVISORS LLC, Director